U.S. Senior District Judge Billy Roy Wilson has been assigned to PhRMA's lawsuit challenging Arkansas’s 340B nondiscrimination act.

New Judge Assigned to PhRMA’s Lawsuit Challenging Arkansas’s First-of-Its-Kind 340B Nondiscrimination Law

A new federal district judge has been assigned to Pharmaceutical Research and Manufacturers of America’s (PhRMA) lawsuit challenging Arkansas’s 340B nondiscrimination act.

PhRMA’s case, filed on Sept. 29, was initially assigned to U.S. District Judge Lee Rudofsky, a Trump appointee. It has been transferred to U.S. Senior District Judge Billy Roy Wilson, a Clinton appointee.

The Arkansas Insurance Department (AID) and Arkansas Attorney General are due to file briefs tomorrow responding to PhRMA’s separate petition asking AID to stay enforcement of the 340B nondiscrimination act pending the outcome of federal lawsuits challenging a federal health agency’s findings that six drug manufacturers’ 340B contract pharmacy restrictions violate the 340B statute. The state hospital and pharmacy associations and Baxter Regional Medical Center also are expected to file a joint brief.